Molnlycke
Molnlycke Mepilex XT 10x10 cm 5s (211100)
Molnlycke Mepilex XT 10x10 cm 5s (211100)
无法加载取货服务可用情况
Product Overview
Mepilex XT 10 x 10 cm is the standard small-format presentation of Mölnlycke’s channelled foam dressing range, suited to digital, peri-malleolar and other smaller anatomical sites. The dressing combines a soft polyurethane foam pad with an inner channelled wound-contact layer bonded with Safetac, the original silicone adhesive technology. Channels in the contact layer transport viscous exudate into the absorbent core while preserving a moist wound environment consistent with TIME (Tissue, Infection/inflammation, Moisture, Edges) wound-bed preparation principles.
Safetac creates a soft seal at the periwound skin that minimises lateral spread of exudate, reducing the risk of maceration and skin stripping at dressing change. Clinical evaluations demonstrate atraumatic removal compared with conventional adhesives, supporting the WUWHS minimising-pain-at-dressing-change consensus and reducing patient-reported pain scores. The dressing can be used under graduated compression therapy in venous leg ulcer management when clinically indicated.
Specifications
| Manufacturer | Mölnlycke Health Care AB (Sweden) |
|---|---|
| Product / REF | Mepilex XT, REF 211100 |
| Dressing Size | 10 cm x 10 cm |
| Pack Size | 5 dressings per carton |
| Construction | Polyurethane absorbent foam pad with channelled Safetac silicone wound-contact layer and vapour-permeable polyurethane backing film |
| Adhesive | Safetac soft silicone (atraumatic, repositionable) |
| Exudate Handling | Absorbs low- to high-viscosity exudate; vertical wicking; reduced lateral spread |
| Sterility | Sterile (ethylene oxide); single-use |
| Latex Content | Not made with natural rubber latex |
| Shelf Life | Refer to outer carton; store below 35°C, dry |
| Regulatory | CE-marked under EU MDR 2017/745; FDA 510(k) cleared (Class II); ISO 13485 quality management system |
| HCPCS | A6209 (foam dressing without adhesive border, <16 sq in) |
Clinical Indications
- Pressure injuries (Stage II and beyond) on heels, sacrum or trochanter where a small-format dressing is appropriate
- Diabetic foot ulcers, especially digital and forefoot lesions
- Smaller venous and arterial leg ulcers under appropriate compression or off-loading
- Skin tears (ISTAP Type 1, 2 and 3) on extremities
- Secondary-healing post-surgical wounds and dehisced incisions of small surface area
- Donor sites and partial-thickness burns under physician supervision
Frequently Asked Questions
Why are exudate channels useful for viscous exudate?
Standard foam dressings rely on capillary uptake, which can stall when exudate is highly viscous (for example sloughy or chronic ulcer exudate). The channelled Safetac contact layer of Mepilex XT provides preferential pathways into the foam core, supporting the moisture-balance objective described in the WUWHS Wound Exudate principles document.
How is the 10 x 10 cm size selected versus 15 x 15 cm?
EWMA practice recommends a dressing margin of at least 1–2 cm beyond the wound edge onto intact periwound skin. The 10 x 10 cm presentation is suited to wounds of approximately 6 x 6 cm or smaller; for larger wounds use 15 x 15 cm or multiple dressings.
Can the dressing be left in place under compression therapy?
Yes, Mepilex XT is designed for use under multilayer compression bandaging. Wear time is determined by clinical assessment of exudate strikethrough, periwound skin condition and infection signs, typically up to 7 days when not saturated.
How is the dressing supplied for Singapore healthcare buyers?
EMIS supplies Mepilex XT 211100 in original Mölnlycke cartons (5 dressings per carton). Product is intended for healthcare-professional use; bulk and institutional pricing for clinics, nursing homes and community-care providers in Singapore is available on request, with HSA-compliant import documentation.
Is Mepilex XT compatible with topical antimicrobials?
Mepilex XT is non-medicated; it is compatible with most topical antiseptics and antimicrobials commonly used in wound bed preparation. Where infection is confirmed or suspected, consider an antimicrobial primary layer (for example Mepilex Ag) consistent with IWII Wound Infection in Clinical Practice 2022 guidance.
分享
